Chimeric antigen receptor T cells therapy in solid tumors.
Rababah F, Alabduh T, Awawdeh A, Shatnawi T, Al-Shdaifat M, Ibdah E, Shatnawi S, AbuZetun Y, Helaly AM, Ghorab DS.
Rababah F, et al.
Clin Transl Oncol. 2023 Aug;25(8):2279-2296. doi: 10.1007/s12094-023-03122-8. Epub 2023 Feb 28.
Clin Transl Oncol. 2023.
PMID: 36853399
Review.
Chimeric antigen receptor T cells therapy (CAR-T therapy) is a class of ACT therapy. Chimeric antigen receptor (CAR) is an engineered synthetic receptor of CAR-T, which give T cells the ability to recognize tumor antigens in a human leukocyte antigen-i …
Chimeric antigen receptor T cells therapy (CAR-T therapy) is a class of ACT therapy. Chimeric antigen receptor (CAR) is an eng …